Femanest Tafla 1 mg Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

femanest tafla 1 mg

viatris aps - estradiol - tafla - 1 mg

Femanest Tafla 2 mg Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

femanest tafla 2 mg

viatris aps - estradiol - tafla - 2 mg

Toradol Stungulyf, lausn 30 mg/ml Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

toradol stungulyf, lausn 30 mg/ml

atnahs pharma netherlands b.v. - ketorolacum trómetamól - stungulyf, lausn - 30 mg/ml

Cipramil Filmuhúðuð tafla 20 mg Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

cipramil filmuhúðuð tafla 20 mg

h. lundbeck a/s* - citalopram hydrobromide - filmuhúðuð tafla - 20 mg

Cipramil Filmuhúðuð tafla 10 mg Islanda - islandeză - LYFJASTOFNUN (Icelandic Medicines Agency)

cipramil filmuhúðuð tafla 10 mg

h. lundbeck a/s* - citalopram hydrobromide - filmuhúðuð tafla - 10 mg

Brintellix Uniunea Europeană - islandeză - EMA (European Medicines Agency)

brintellix

h. lundbeck a/s - vortioxetine - Þunglyndi, major - psychoanaleptics, - meðferð við alvarlegum þunglyndisþáttum hjá fullorðnum.

Fabrazyme Uniunea Europeană - islandeză - EMA (European Medicines Agency)

fabrazyme

sanofi b.v. - agalsidasa beta - fabry sjúkdómur - Önnur meltingarvegi og efnaskipti vörur, - fabrazyme er ætlað til langtíma ensímuppbótarmeðferðar hjá sjúklingum með staðfestan sjúkdóm af fabry-sjúkdómum (α-galaktósíðasa-a skort).

Hemangiol Uniunea Europeană - islandeză - EMA (European Medicines Agency)

hemangiol

pierre fabre medicament - própranólól hýdróklóríð - hemangioma - betablokkar - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.

Kyprolis Uniunea Europeană - islandeză - EMA (European Medicines Agency)

kyprolis

amgen europe b.v. - carfilzomib - mergæxli - Æxlishemjandi lyf - kyprolis in combination with daratumumab and dexamethasone, with lenalidomide and dexamethasone, or with dexamethasone alone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.

Methylthioninium chloride Proveblue Uniunea Europeană - islandeză - EMA (European Medicines Agency)

methylthioninium chloride proveblue

provepharm sas - metýlþíóníumklóríð - methemóglóbíndreyri - Öll önnur lækningavörur - bráð einkenni meðhöndlunar á methemóglóbíndreyri í lyfjum og efnaafurðum. methylthioninium i proveblue er ætlað í fullorðnir, börn og unglingar (aldrinum 0 til 17 ára).